Clinical Study

A011401-Randomized Phase III Trial Evaluating The Role Of Weight Loss In Adjuvant Treatment Of Overweight And Obese Women With Early Breast Cancer.

Posted Date: May 15, 2019

  • Investigator: Elizabeth Shaughnessy
  • Specialties: Breast Cancer, Cancer, Oncology
  • Type of Study: Observational/Survey

To compare the effect of a supervised weight loss intervention plus health education materials versus health education materials alone upon invasive disease free survival (iDFS) in overweight (BMI 27-29.9 kg/m2) and obese (BMI =30kg/m2) women diagnosed with HER-2 negative, stage II and III breast cancer.

Criteria:

To Be Eligible: Patients Must Be 18+ Years Of Age, Patients Must Be Overweight (Bmi > 27) Or Obese Women With Stage 2 Or 3 Breast Cancer, Not Diabetic, No Other Malignancy In Past 4 Years

Keywords:

Breast Cancer, Breast, Weight Loss, Cancer, Phase Iii

For More Information:

Uc Cancer Center
513-584-7698
cancer@uchealth.com